CJC-1295: Mechanism, Benefits, and What the Evidence Actually Shows What is CJC-1295
For patients considering semaglutide or already taking it, this information is critical
The advantage of compounding is cost ($149/mo starting) and flexibility in dose titration, which can help providers adjust more carefully for patients with sensitive stomachs
A control group ( n = 12) compared to type 2 diabetes mellitus patients ( n = 16) had lower levels of glycemia, flow-mediated vasodilation (FMD), plasma nitrotyrosine and plasma 8-iso prostaglandin F2 (8-iso-PGF2a) after standar meal and oral glucose tolerance test (OGTT) and after two months of insulin treatment
My assumption is that, within the next 12-18 months, we will get something from [big] pharma and the FDA stating that a select amount [of peptides] will most likely be deemed Class 1 [from their current Class 2], which will mean that theyre legal to compound [in the U.S
Join us on a journey to a healthier you, where expert care meets compassion